Braasch Biotech LLC, an emerging biopharmaceutical company pioneering a new field of anti-somatostatin vaccines, today announced a Notice of Allowance was received from the Japan Patent Office on July 15, 2025, for Braasch's patent entitled...
The United States vaccine market was valued at around USD 29.5 billion in 2024 and is projected to reach around USD 60 billion by 2033, exhibiting a CAGR of 8 % during the forecast period.
The global influenza vaccine market size was valued at USD 7.8 billion in 2023 and is likely to reach USD 13.7 billion in 2032, expanding at a CAGR of 7.2% during the forecast period.